OR WAIT null SECS
February 02, 2009
Without any GMP guidelines for excipients in Europe, change can't come soon enough for some industry groups.
Brief pharmaceutical news items for February 2009.
The pharmaceutical majors forward projects in biocatalysis, solvent replacement, and other approaches in green chemistry.
A recent reader poll focused on predictions for the industry's future.
FDA's role should not be overlooked as it has been in years past.
February 01, 2009
During the past years, there has been increasing demand for fast dissolving disintegrating tablets (FDDTs), such as orally disintegrating tablets (ODTs) and sublinguals.
January 29, 2009
Also, UCB will divest certain business in emerging markets to GSK; the KineMatik Group named Michael G. Jarjour president and CEO; more...
Pfizer will purchase Wyeth (Madison, NJ) under a definitive merger agreement approved by both companies' boards of directors.
January 22, 2009
Also, Elan explores strategic alternatives; NanoGuardian appoints John D. Glover to lead its Security Advisory Board; more...
January 15, 2009
Also, Bristol-Myers Squibb forms collaboration with ZymoGenetics, Hana Biosciences appoints VP of regulatory affairs, more...